Literature DB >> 1940983

Complement allotypes in familial and sporadic Alzheimer's disease.

P K Panegyres1, R L Dawkins.   

Abstract

To resolve conflicting findings on the association of complement allotypes with Alzheimer's disease (AD) we have studied the C4 phenotypes in 33 sporadic cases and in one family with familial AD. We found no association with complement alleles in familial or sporadic AD, even though a familial case had absence of the C4 null allele (C4BQ0). Our data do not suggest a role for complement genes in the pathogenesis of AD. It also seems that the C4B2 allele cannot be used as a marker for AD as has been suggested by others.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1940983     DOI: 10.1007/bf00315331

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  13 in total

1.  [Absence of a connection between Alzheimer's disease and complement markers].

Authors:  S Clémenceau; J F Foncin; J Y Muller; L Halle; G Hauptmann; J Seger; C Salmon
Journal:  C R Acad Sci III       Date:  1986

2.  Complement C4 phenotypes in dementia of the Alzheimer type.

Authors:  P Eikelenboom; J Goetz; J C Pronk; G Hauptmann
Journal:  Hum Hered       Date:  1988       Impact factor: 0.444

3.  Two HLA-linked loci controlling the fourth component of human complement.

Authors:  G J O'Neill; S Y Yang; B Dupont
Journal:  Proc Natl Acad Sci U S A       Date:  1978-10       Impact factor: 11.205

4.  Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study.

Authors:  P Eikelenboom; F C Stam
Journal:  Acta Neuropathol       Date:  1982       Impact factor: 17.088

5.  Amyloid A4 protein and its precursor in Down's syndrome and Alzheimer's disease.

Authors:  B Rumble; R Retallack; C Hilbich; G Simms; G Multhaup; R Martins; A Hockey; P Montgomery; K Beyreuther; C L Masters
Journal:  N Engl J Med       Date:  1989-06-01       Impact factor: 91.245

6.  HLA-linked complement markers in Alzheimer's and Parkinson's disease: C4 variant (C4B2) a possible marker for senile dementia of the Alzheimer type.

Authors:  C Nerl; R Mayeux; G J O'Neill
Journal:  Neurology       Date:  1984-03       Impact factor: 9.910

7.  Complement allotyping in SLE: association with C4A null.

Authors:  F T Christiansen; R L Dawkins; G Uko; J McCluskey; P H Kay; P J Zilko
Journal:  Aust N Z J Med       Date:  1983-10

8.  Amyloid plaque core protein in Alzheimer disease and Down syndrome.

Authors:  C L Masters; G Simms; N A Weinman; G Multhaup; B L McDonald; K Beyreuther
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

9.  Familial Alzheimer's disease in two kindreds of the same geographic and ethnic origin. A clinical and genetic study.

Authors:  J Goudsmit; B J White; L R Weitkamp; B J Keats; C H Morrow; D C Gajdusek
Journal:  J Neurol Sci       Date:  1981-01       Impact factor: 3.181

10.  Genetic polymorphism in human glycine-rich beta-glycoprotein.

Authors:  C A Alper; T Boenisch; L Watson
Journal:  J Exp Med       Date:  1972-01       Impact factor: 14.307

View more
  1 in total

1.  Protein phosphatase 2A and complement component 4 are linked to the protective effect of APOE ɛ2 for Alzheimer's disease.

Authors:  Gyungah R Jun; Yang You; Congcong Zhu; Gaoyuan Meng; Jaeyoon Chung; Rebecca Panitch; Junming Hu; Weiming Xia; David A Bennett; Tatiana M Foroud; Li-San Wang; Jonathan L Haines; Richard Mayeux; Margaret A Pericak-Vance; Gerard D Schellenberg; Rhoda Au; Kathryn L Lunetta; Tsuneya Ikezu; Thor D Stein; Lindsay A Farrer
Journal:  Alzheimers Dement       Date:  2022-02-09       Impact factor: 16.655

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.